Since 2017, JELLICE Taiwan has implemented the “three-dimensional development strategy” to respond to the transformation of the protein peptide industry. The company focuses on horizontal integration in gelatin and collagen manufacturing and cross-industry applications, driving the development of high-value and specialized products.

In 2021, the Bioactive Peptide Research Center was established, recruiting top-tier researchers and collaborating with with leading universities and research institutes in Taiwan, including the Industrial Technology Research Institute (ITRI).Through this functional peptide industry-academia alliance, Jellice Taiwan develops high-value bioactive peptide raw materials, accelerates the commercialization of laboratory results, and promotes knowledge exchange and talent cultivation.

JELLICE Taiwan and Japanese parent company, serves as one of the two main R&D centers of the JELLICE Group, focusing on flexible development of high-value and specialized products. It has become the core of the Group’s technology and innovation, leading global advancements in gelatin and collagen technologies.

JELLICE Taiwan holds multiple patents including CollaMeta preparation, tripeptide micro-particle systems, continuous extraction, and highly soluble porous powders. Its patents covering Taiwan, the Netherlands, Germany, and are pending in France, demonstrating a strategic European patent layout and international influence in collagen technology.
Leveraging years of expertise, JELLICE Taiwan has achieved outstanding results across the health supplement, cosmetics, electronics, and textile fiber industries, continuously innovating to maintain the Group’s global competitiveness.